Atypical acute Helicobacter pylori infection without atrophic gastritis: A case report
Fujita Medical Journal · 2026-08 · 12 (3) · 246-250
DOI: 10.20407/fmj.2025-050 ↗Kurz gefasst
Fallbericht in der Zeitschrift Fujita Medical Journal, 2026-08. Verfasst von Ryuzo Deguchi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Fujita Health University Haneda Clinic, Ota, Tokyo, Japan. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
A 64-year-old Chinese man visited our clinic’s health-screening center. The patient tested negative for Helicobacter pylori (HP) infection in his home country, but at this visit, anti-HP antibodies of 5 U/mL and a urea breath test (UBT) result of 48.6‰ were detected. Upper gastrointestinal endoscopy showed no atrophic gastritis, and a regular arrangement of collecting venules was observed. Since a false-positive UBT was also considered, Smart Gene testing was performed, which confirmed the HP positivity. As no clarithromycin resistance mutation was detected, Japan’s first-line eradication regimen was prescribed. The eradication test result was a UBT of 0.1‰, confirming successful HP eradication.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Fujita Health University Haneda Clinic, Ota, Tokyo, Japan.
Zitieren
APA
Deguchi, R., & Ogata, H. (2026). Atypical acute Helicobacter pylori infection without atrophic gastritis: A case report. Fujita Medical Journal, 12(3), 246-250. https://doi.org/10.20407/fmj.2025-050
Vancouver
Deguchi R, Ogata H. Atypical acute Helicobacter pylori infection without atrophic gastritis: A case report. Fujita Medical Journal. 2026;12(3):246-250. doi:10.20407/fmj.2025-050
BibTeX
@article{Deguchi2026,
author = {Deguchi, Ryuzo and Ogata, Haruhiko},
title = {Atypical acute Helicobacter pylori infection without atrophic gastritis: A case report},
journal = {Fujita Medical Journal},
year = {2026},
volume = {12},
number = {3},
pages = {246--250},
doi = {10.20407/fmj.2025-050}
}
EUVIMED